REVEN PHARMACEUTICALS
Reven Pharmaceuticals, Inc.
Mark For: REVEN PHARMACEUTICALS® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 86628046 |
| Registration Number | 5686422 |
| Mark Literal Elements | REVEN PHARMACEUTICALS |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | SERVICE MARK |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2019-01-23 |
| Basis | 1(a) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | Yes |
| Intent To Use | No |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Michael F. Snyder |
| Attorney Docket Number | RPI2-TM002 |
| Law Office Assigned | M80 |
| Employee Name | JACKSON, WILLIAM D |
Timeline
| 2015-05-13 | Application Filed |
| 2015-10-27 | Published |
| 2015-10-27 | Published for Opposition |
| 2018-06-25 | Location: INTENT TO USE SECTION |
| 2018-06-25 | Status: Live/Pending |
| 2018-12-21 | Date of First Use |
| 2018-12-21 | Date of Use In Commerce |
| 2019-01-02 | Transaction Date |
| 2019-01-23 | Location: PUBLICATION AND ISSUE SECTION |
| 2019-02-26 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
| 2019-02-26 | Trademark Registered |
| 2024-02-26 | Maintenance Early File Date |
| 2025-02-26 | Maintenance On Time Date |
| 2025-08-26 | Maintenance Late Fee Date |
Trademark Parties (Applicants & Owners)
| Party: |  Reven Pharmaceuticals, Inc. |
| Address | 600 Corporate Circle #C Golden, COLORADO UNITED STATES 80401 |
| Legal Entity Type | Corporation |
| Legal Entity State | FLORIDA |
Documents
Drawing
TEAS RF New ApplicationAttorney of Record
Good, Services, and Codes
IC 042. US 100 101. G & S: Pharmaceutical research and development in the fields of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease; Pharmaceutical services, namely, the development of pharmaceuticals for the treatment of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease. FIRST USE: 20181221. FIRST USE IN COMMERCE: 20181221
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| TR0010 | The wording "REVEN" has no meaning in a foreign language. |
| D10000 | "PHARMACEUTICALS" |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| REGISTERED-PRINCIPAL REGISTER | 2019-02-26 | |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2019-01-24 | |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2019-01-23 | |
| STATEMENT OF USE PROCESSING COMPLETE | 2019-01-09 | 69302 |
| TEAS STATEMENT OF USE RECEIVED | 2018-12-26 | |
| USE AMENDMENT FILED | 2018-12-24 | 69302 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-06-26 | |
| EXTENSION 5 GRANTED | 2018-06-25 | 69302 |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2018-06-25 | 69302 |
| TEAS EXTENSION RECEIVED | 2018-06-22 | |
| EXTENSION 5 FILED | 2018-06-22 | 69302 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2017-12-23 | |
| TEAS EXTENSION RECEIVED | 2017-12-21 | |
| EXTENSION 4 GRANTED | 2017-12-21 | 98765 |
| EXTENSION 4 FILED | 2017-12-21 | 98765 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2017-06-24 | |
| TEAS EXTENSION RECEIVED | 2017-06-22 | |
| EXTENSION 3 GRANTED | 2017-06-22 | 98765 |
| EXTENSION 3 FILED | 2017-06-22 | 98765 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2016-12-24 | |
| TEAS EXTENSION RECEIVED | 2016-12-22 | |
| EXTENSION 2 GRANTED | 2016-12-22 | 98765 |
| EXTENSION 2 FILED | 2016-12-22 | 98765 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2016-06-24 | |
| TEAS EXTENSION RECEIVED | 2016-06-22 | |
| EXTENSION 1 GRANTED | 2016-06-22 | 98765 |
| EXTENSION 1 FILED | 2016-06-22 | 98765 |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2015-12-22 | |
| PUBLISHED FOR OPPOSITION | 2015-10-27 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2015-10-27 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2015-10-07 | |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2015-09-18 | 77312 |
| ASSIGNED TO LIE | 2015-09-17 | 77312 |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2015-08-21 | 6328 |
| EXAMINERS AMENDMENT E-MAILED | 2015-08-21 | 6328 |
| EXAMINERS AMENDMENT -WRITTEN | 2015-08-21 | 74666 |
| EXAMINER'S AMENDMENT ENTERED | 2015-08-21 | 88888 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2015-08-21 | |
| ASSIGNED TO EXAMINER | 2015-08-19 | 74666 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2015-05-20 | |
| NEW APPLICATION ENTERED IN TRAM | 2015-05-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 